• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前内镜活检可代表食管及食管胃交界腺癌的组织学类型和生存风险。

Pre-Surgical Endoscopic Biopsies Are Representative of Esophageal and Esophago-Gastric Junction Adenocarcinoma Histologic Classes and Survival Risk.

作者信息

Gambella Alessandro, Fiocca Roberto, Lugaresi Marialuisa, D'Errico Antonietta, Malvi Deborah, Spaggiari Paola, Tomezzoli Anna, Albarello Luca, Ristimäki Ari, Bottiglieri Luca, Bonora Elena, Krishnadath Kausilia K, Raulli Gian Domenico, Rosati Riccardo, Romario Uberto Fumagalli, De Manzoni Giovanni, Räsänen Jari, Mattioli Sandro, Grillo Federica, Mastracci Luca

机构信息

Pathology Unit, Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, 16132 Genoa, Italy.

Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum, University of Bologna, 40126 Bologna, Italy.

出版信息

Cancers (Basel). 2024 Dec 2;16(23):4045. doi: 10.3390/cancers16234045.

DOI:
10.3390/cancers16234045
PMID:39682231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11640587/
Abstract

The Esophageal Adenocarcinoma Study Group Europe (EACSGE) recently proposed a granular histologic classification of esophageal-esophago-gastric junctional adenocarcinomas (EA-EGJAs) based on the study of naïve surgically resected specimens that, when combined with the pTNM stage, is an efficient indicator of prognosis, molecular events, and response to treatment. In this study, we compared histologic classes of endoscopic biopsies taken before surgical resection with those of the surgical specimen, to evaluate the potential of the EACSGE classification at the initial diagnostic workup. A total of 106 EA-EGJA cases with available endoscopic biopsies and matched surgical resection specimens were retrieved from five Italian institutions. Histologic classification was performed on all specimens to identify well-differentiated glandular adenocarcinoma (WD-GAC), poorly differentiated glandular adenocarcinoma (PD-GAC), mucinous muconodular carcinoma (MMC), infiltrative mucinous carcinoma (IMC), diffuse desmoplastic carcinoma, diffuse anaplastic carcinoma (DAC), and mixed subtypes. Related risk subgroups (low-risk versus high-risk) were also assessed. The correlations of histologic classes and risk subgroups between diagnostic biopsies and surgical resection specimens were explored with Spearman's correlation test. Sensitivity, specificity, accuracy, positive predictive value, negative predictive value, true positives, true negatives, false positives, and false negatives were also calculated. A strong positive correlation between biopsies and surgical specimens occurred for both histologic classes (coefficient: 0.75, < 0.001) and risk subgroups (coefficient: 0.65, < 0.001). The highest sensitivities and specificities were observed for MMC, IMC, and DAC (100% and 99% for all), followed by WD-GAC (sensitivity 91%, specificity 79%) and PD-GAC (sensitivity 722%, specificity 86%). The low-risk and high-risk groups presented a sensitivity and specificity of 89% and 76% (low-risk) and 76% and 89% (high-risk). The EACSGE histologic classification of EA-EGJAs and associated prognostic subgroups can be reliably assessed on pre-operative diagnostic biopsies. Further studies on larger and more representative cohorts of EA-EGJAs will allow us to validate our findings and confirm if the EA-EGJA biopsy histomorphology and clinical TNM staging will be as efficient as the surgical specimen histomorphology and pTNM in predicting patient prognoses and tailoring personalized therapeutic approaches.

摘要

欧洲食管腺癌研究组(EACSGE)最近基于对未经处理的手术切除标本的研究,提出了食管-食管胃交界腺癌(EA-EGJAs)的颗粒状组织学分类,该分类与pTNM分期相结合,是预后、分子事件及治疗反应的有效指标。在本研究中,我们比较了手术切除前获取的内镜活检组织学类别与手术标本的组织学类别,以评估EACSGE分类在初始诊断检查中的潜力。从五家意大利机构检索到106例有可用内镜活检及匹配手术切除标本的EA-EGJA病例。对所有标本进行组织学分类,以识别高分化腺腺癌(WD-GAC)、低分化腺腺癌(PD-GAC)、黏液性黏液结节癌(MMC)、浸润性黏液癌(IMC)、弥漫性促纤维组织增生性癌、弥漫性间变性癌(DAC)及混合亚型。还评估了相关风险亚组(低风险与高风险)。采用Spearman相关性检验探索诊断活检与手术切除标本之间组织学类别及风险亚组的相关性。还计算了敏感性、特异性、准确性、阳性预测值、阴性预测值、真阳性、真阴性、假阳性及假阴性。活检与手术标本在组织学类别(系数:0.75,<0.001)及风险亚组(系数:0.65,<0.001)方面均存在强正相关。MMC、IMC和DAC的敏感性和特异性最高(均为100%和99%),其次是WD-GAC(敏感性91%,特异性79%)和PD-GAC(敏感性722%,特异性86%)。低风险和高风险组的敏感性和特异性分别为89%和76%(低风险)以及76%和89%(高风险)。EA-EGJAs的EACSGE组织学分类及相关预后亚组可通过术前诊断活检可靠评估。对更大且更具代表性的EA-EGJA队列进行进一步研究,将使我们能够验证我们的发现,并确认EA-EGJA活检组织形态学和临床TNM分期在预测患者预后及制定个性化治疗方案方面是否与手术标本组织形态学和pTNM一样有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b884/11640587/5a7c88429231/cancers-16-04045-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b884/11640587/da588caefc78/cancers-16-04045-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b884/11640587/94c499352345/cancers-16-04045-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b884/11640587/1cebef2ce236/cancers-16-04045-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b884/11640587/5a7c88429231/cancers-16-04045-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b884/11640587/da588caefc78/cancers-16-04045-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b884/11640587/94c499352345/cancers-16-04045-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b884/11640587/1cebef2ce236/cancers-16-04045-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b884/11640587/5a7c88429231/cancers-16-04045-g004.jpg

相似文献

1
Pre-Surgical Endoscopic Biopsies Are Representative of Esophageal and Esophago-Gastric Junction Adenocarcinoma Histologic Classes and Survival Risk.术前内镜活检可代表食管及食管胃交界腺癌的组织学类型和生存风险。
Cancers (Basel). 2024 Dec 2;16(23):4045. doi: 10.3390/cancers16234045.
2
The Prognostic Impact of Histology in Esophageal and Esophago-Gastric Junction Adenocarcinoma.组织学对食管及食管胃交界腺癌预后的影响
Cancers (Basel). 2021 Oct 18;13(20):5211. doi: 10.3390/cancers13205211.
3
Histologic grading based on counting poorly differentiated clusters in preoperative biopsy predicts nodal involvement and pTNM stage in colorectal cancer patients.基于术前活检中计数低分化簇的组织学分级可预测结直肠癌患者的淋巴结受累和 pTNM 分期。
Hum Pathol. 2014 Feb;45(2):268-75. doi: 10.1016/j.humpath.2013.07.046. Epub 2013 Nov 27.
4
Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.使用内镜超声和腹腔镜超声对上消化道癌患者进行治疗前评估。
Dan Med J. 2012 Dec;59(12):B4568.
5
A quantitative imaging biomarker for predicting disease-free-survival-associated histologic subgroups in lung adenocarcinoma.用于预测肺腺癌无病生存相关组织学亚组的定量成像生物标志物。
Eur Radiol. 2020 Jul;30(7):3614-3623. doi: 10.1007/s00330-020-06663-6. Epub 2020 Feb 21.
6
Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025.胃上皮癌前病变和早期肿瘤的管理(MAPS III):欧洲胃肠内镜学会(ESGE)、欧洲幽门螺杆菌与微生物群研究组(EHMSG)及欧洲病理学会(ESP)2025年指南更新
Endoscopy. 2025 May;57(5):504-554. doi: 10.1055/a-2529-5025. Epub 2025 Mar 20.
7
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.国际肺癌研究协会/美国胸科学会/欧洲呼吸学会国际多学科肺腺癌分类。
J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221.
8
Tumoral Morphologic Features From Cervical Biopsies That Are Predictive of a Negligible Risk for Nodal Metastasis and Tumor Recurrence in Usual-type Cervical Adenocarcinomas: A Multi-institutional Study.宫颈活检中提示局灶型宫颈腺癌发生淋巴结转移和肿瘤复发风险低的肿瘤形态学特征:一项多中心研究。
Am J Surg Pathol. 2022 May 1;46(5):713-724. doi: 10.1097/PAS.0000000000001833.
9
Correlation of endoscopic and histologic findings before and after treatment for nasopharyngeal carcinoma.鼻咽癌治疗前后内镜检查结果与组织学检查结果的相关性
Head Neck. 2001 Jan;23(1):34-41.
10
Utility of Core Biopsy Specimen to Identify Histologic Subtype and Predict Outcome for Lung Adenocarcinoma.核心活检标本对肺腺癌组织学分型和预测预后的作用。
Ann Thorac Surg. 2019 Aug;108(2):392-398. doi: 10.1016/j.athoracsur.2019.03.043. Epub 2019 Apr 12.

本文引用的文献

1
Oesophageal cancer.食管癌。
Lancet. 2024 Nov 16;404(10466):1991-2005. doi: 10.1016/S0140-6736(24)02226-8.
2
The integrated molecular and histological analysis defines subtypes of esophageal squamous cell carcinoma.综合分子和组织学分析定义了食管鳞癌的亚型。
Nat Commun. 2024 Oct 18;15(1):8988. doi: 10.1038/s41467-024-53164-x.
3
Long-term outcomes of endoscopic submucosal dissection for early esophageal adenocarcinoma in the Eastern population: a comprehensive analysis.东方人群早期食管腺癌内镜黏膜下剥离术的长期疗效:一项综合分析。
J Gastrointest Surg. 2024 Dec;28(12):1988-1993. doi: 10.1016/j.gassur.2024.09.012. Epub 2024 Sep 18.
4
Somatic mutations of esophageal adenocarcinoma: a comparison between Black and White patients.食管腺癌的体细胞突变:黑人和白人患者之间的比较。
Sci Rep. 2024 Apr 18;14(1):8988. doi: 10.1038/s41598-024-59257-3.
5
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
6
miRNA-221 and miRNA-483-3p Dysregulation in Esophageal Adenocarcinoma.食管腺癌中miRNA - 221和miRNA - 483 - 3p的失调
Cancers (Basel). 2024 Jan 30;16(3):591. doi: 10.3390/cancers16030591.
7
Comparison of TNM AJCC/UICC 8th with JES 11th staging systems for prognostic prediction in patients with esophageal squamous cell carcinoma who underwent radical (chemo) radiotherapy in China.中国接受根治性(放化疗)的食管鳞癌患者中,AJCC/UICC 第 8 版 TNM 与 JES 第 11 版分期系统的预后预测比较。
J Cancer Res Ther. 2023 Dec 1;19(6):1610-1619. doi: 10.4103/jcrt.jcrt_447_23. Epub 2023 Dec 28.
8
The association between histological subtypes and lymph node metastasis and prognosis in early esophageal cancer: a population-based study.早期食管癌中组织学亚型与淋巴结转移及预后的关系:一项基于人群的研究。
Eur J Cancer Prev. 2024 Mar 1;33(2):152-160. doi: 10.1097/CEJ.0000000000000847. Epub 2023 Nov 6.
9
Population Based Time Trends in the Epidemiology and Mortality of Gastroesophageal Junction and Esophageal Adenocarcinoma.基于人群的胃食管结合部和食管腺癌的流行病学和死亡率的时间趋势。
Dig Dis Sci. 2024 Jan;69(1):246-253. doi: 10.1007/s10620-023-08126-6. Epub 2023 Nov 1.
10
Esophageal Cancer: Overview, Risk Factors, and Reasons for the Rise.食管癌:概述、危险因素和发病率上升的原因。
Curr Gastroenterol Rep. 2023 Nov;25(11):275-279. doi: 10.1007/s11894-023-00899-0. Epub 2023 Oct 9.